Strides Pharma Science Balance Sheet Health
Financial Health criteria checks 2/6
Strides Pharma Science has a total shareholder equity of ₹19.9B and total debt of ₹27.9B, which brings its debt-to-equity ratio to 140.2%. Its total assets and total liabilities are ₹63.4B and ₹43.4B respectively. Strides Pharma Science's EBIT is ₹3.9B making its interest coverage ratio 2. It has cash and short-term investments of ₹3.3B.
Key information
140.2%
Debt to equity ratio
₹27.95b
Debt
Interest coverage ratio | 2x |
Cash | ₹3.26b |
Equity | ₹19.94b |
Total liabilities | ₹43.44b |
Total assets | ₹63.38b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 532531's short term assets (₹33.9B) exceed its short term liabilities (₹31.4B).
Long Term Liabilities: 532531's short term assets (₹33.9B) exceed its long term liabilities (₹12.1B).
Debt to Equity History and Analysis
Debt Level: 532531's net debt to equity ratio (123.8%) is considered high.
Reducing Debt: 532531's debt to equity ratio has increased from 113.2% to 140.2% over the past 5 years.
Debt Coverage: 532531's debt is not well covered by operating cash flow (14%).
Interest Coverage: 532531's interest payments on its debt are not well covered by EBIT (2x coverage).